preventive-health
(21)
Paceline and the Credit Card That Learned to Walk
Paceline tried to turn exercise into a financial asset. Its first credit card disappeared, but the useful idea survived - and came back as a marketplace built on sweat, data, and one stubborn weekly number.
The Second Blood Test Is the Point
Superpower sells 150-plus biomarkers, an AI-assisted plan and a second look at your blood. The interesting product is not the test. It is the feedback loop after it.
The $10,000 Oil Change for Humans: How Circulate Sold Blood Cleaning Before Longevity Was Proven
Circulate turned a decades-old hospital procedure into a private-pay longevity service, raised $12 million and sold to Viome. Its smartest product may not be plasma exchange at all - it is the operating system that lets clinics offer a complicated treatment while the science catches up.
The $299 Seoul Checkup: How Himedi Turned Healthcare Friction Into a Concierge Business
A routine physical in America can feel like an appetizer. Himedi sells the Korean alternative - dozens of tests in one morning - then handles the translation, booking and nerves around it.
Restore Turned a Bad Cryotherapy Visit Into a 200-Studio Wellness Machine
The founders thought athletes would fill the cryo chamber. They were wrong - and that mistake revealed a much larger market for convenient, repeatable wellness under one roof.
Longevity Science Left the Clinic. Lifespanning Put It in a Shopping Cart.
A Miami media company spent two decades inside biohacking's inner circle. Now it grades 1,000+ longevity products against a 72-point rubric - and only sells the ones that survive.
ConnectedLife Wants Your Wearable to Notice Trouble Before You Do
The Dubai-headquartered health platform is trying to turn the daily exhaust of modern life - sleep, steps, stress, blood pressure and more - into an early-warning system people and clinicians can actually use.
The Raleigh Holding Company Building a Wellness Stack in Plain Sight
MDO Holdings started with a gym and grew into something harder to label: part operator, part investor, part landlord. Its most revealing product may be the connective tissue between the businesses it owns.
Aktivo Labs
Aktivo Labs is a Singapore-based digital health-science company that turns everyday smartphone and wearable data into a proprietary digital biomarker, the Aktivo Score, a 1-99 measure of an individual's risk for chronic disease. It sells its platform to life and health insurers, reinsurers and employers, helping them run evidence-based wellness programs and understand population health risk. Founded in 2017, the company raised a US$10M Series A led by Mitsui & Co. in 2022 and operates across Asia-Pacific with expansion into the US, Europe and Japan.
Healthlane
Healthlane is an African preventive-health company (Y Combinator W20) that pairs a mobile app with a network of diagnostic laboratories to give people personalized health checkups and screening. Founded by Alain Nteff and Dr. Agbor Ashumanyi Ako, it grew out of the maternal-health service GiftedMom with a goal of catching disease early rather than treating it late.
Doctor Anywhere
Doctor Anywhere is a Singapore-headquartered, tech-led healthcare company founded in 2017 by Lim Wai Mun. It started as a telemedicine app that put a licensed doctor on a video call within minutes, then deliberately grew downward into the physical world - GP clinics, specialist practices, health screening and imaging suites, home visits, medication delivery and an in-app health marketplace. The company describes the result as a 'Hospital Anywhere' model: one app that carries a patient from a 2am sore throat to a knee surgeon, across Singapore, Malaysia, Thailand, Indonesia and the Philippines. It serves roughly 3 million users, sells to consumers, corporates and insurers, and has raised about US$176 million from investors including Asia Partners, Novo Holdings, Square Peg, EDBI, IHH Healthcare, Philips and Pavilion Capital.
Imagene Labs
Imagene Labs is a Singapore-based health-tech company that runs an enterprise-grade, cloud-based B2B genetic analytics platform. Using patented ancestry-based genetic risk analytics and ethnically-relevant reference datasets, it turns a simple saliva sample into DNA insights that fitness, beauty, nutrition and healthcare brands use to build personalized products and services. Its consumer-facing brand, Ori, packages these insights into fitness, skincare and nutrition DNA tests for the Asian market and beyond.
Naluri
Naluri is a Southeast Asian digital health company that helps employers and insurers predict, prevent and manage chronic and mental health conditions. Founded in Kuala Lumpur in 2017, it combines behavioural science, data science and licensed health coaches - psychologists, dietitians, fitness and financial coaches - inside a single app to deliver structured, clinically-informed care for conditions such as diabetes, heart disease, obesity, chronic stress, anxiety and depression. Its programmes span Employee Assistance (EAP), chronic disease management and crisis support, serving over 200 employer clients and more than one million members across the region.
Function Health
Function Health is an Austin-based membership platform that gives consumers direct access to 100-plus lab tests, optional full-body MRI scans, and AI-generated insights for a flat annual fee. Founded in 2021 and led by CEO Jonathan Swerdlin with physician co-founder Mark Hyman, the company sells a data-first, preventive approach to healthcare aimed at helping members catch problems early and track their biology over time. After a $298M Series B in November 2025 at a $2.5B valuation, Function has become one of the fastest-growing consumer health companies in the US.
GlycanAge
GlycanAge is a UK-registered, Croatian-founded longevity biotech that measures biological age by analyzing glycans - sugar molecules attached to immune-system antibodies. Built on roughly two decades of glycobiology research led by Professor Gordan Lauc, the company turns a finger-prick blood sample into a report on how fast a person is aging at the molecular level, plus a specialist consultation to guide lifestyle changes. It sells directly to consumers and is expanding its glycan biomarkers into hospitals and preventive-care systems.
DexaFit
DexaFit is a health-testing company that turns a quick, low-radiation full-body DXA scan into a broad picture of a person's health - body composition, bone density, visceral fat and metabolic markers. Its AI arm, DexaFit Dx, layers machine learning on top of those same scans to screen for major chronic diseases such as coronary artery disease and type 2 diabetes, aiming to catch them early and non-invasively. Founded in Chicago in 2011 and now operating dozens of centers, DexaFit pairs in-person testing with an app that translates results into longevity scores, disease-risk estimates and trackable goals.
InsideTracker
InsideTracker is a Cambridge, Massachusetts personalized health and wellness company (legally Segterra, Inc.) that turns your blood, DNA, and wearable data into a science-backed action plan. Founded in 2009 by MIT-trained scientist Dr. Gil Blander, the platform analyzes dozens of blood biomarkers, estimates your biological 'InnerAge,' and recommends specific foods, supplements, and lifestyle changes to optimize performance, healthspan, and longevity. It has become a favorite of athletes and quantified-self enthusiasts and integrates directly with Garmin, Fitbit, Oura, and Apple devices.
DeLorean Artificial Intelligence
DeLorean Artificial Intelligence is a Palm Beach, Florida-based healthcare AI company that builds predictive and interventive intelligence to forecast chronic disease and recommend next-best clinical actions before a patient gets sicker. Its flagship Medical AI platform, MARTI, analyzes structured and unstructured health records to predict events like hospitalizations and disease progression - and is described as the first medical AI to be biologically validated by independent third parties. Founded in 2019 by Dr. Severence MacLaughlin, the company also applies its predictive engine to sales/CRM, life sciences, financial services and other industries.
Nucleus Genomics
Nucleus Genomics is a New York-based consumer genomics company that sells a $399 at-home, clinical-grade whole-genome sequencing kit and a software platform that turns a person's full DNA sequence into readable reports on disease risk, carrier status, traits, and longevity. Founded in 2021 by Thiel Fellow Kian Sadeghi, Nucleus pairs whole-genome data with polygenic risk scores and lifestyle inputs to estimate risk for common, complex conditions. In 2025 it expanded into reproductive products - carrier screening, partner DNA alignment, and a controversial embryo-ranking tool, Nucleus Embryo - that put the company at the center of a public debate over the science and ethics of genetic selection.
Tiny Health
Tiny Health is an Austin-based health company that built the first at-home gut microbiome test designed for babies, then extended the same clinically-validated science to children, pregnant people, adults and longevity. It pairs DNA sequencing of stool and vaginal samples with age-specific reference ranges and personalized, research-backed recommendations, aiming to catch early microbiome imbalances linked to eczema, allergies, digestive issues and chronic conditions before they take hold.
Prenuvo
Prenuvo runs a chain of clinics built around a 60-minute whole-body MRI designed to spot cancer, aneurysms and hundreds of other conditions before symptoms show up. Founded by Andrew Lacy and radiologist Raj Attariwala, the company is trying to drag American healthcare from reactive to preventive, one scan at a time.